HK1145837A1 - Amide derivative and pharmaceutical composition containing the same - Google Patents
Amide derivative and pharmaceutical composition containing the sameInfo
- Publication number
- HK1145837A1 HK1145837A1 HK11100055.9A HK11100055A HK1145837A1 HK 1145837 A1 HK1145837 A1 HK 1145837A1 HK 11100055 A HK11100055 A HK 11100055A HK 1145837 A1 HK1145837 A1 HK 1145837A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- same
- pharmaceutical composition
- composition containing
- amide derivative
- amide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Otolaryngology (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008040029 | 2008-02-21 | ||
| PCT/JP2009/053011 WO2009104729A1 (ja) | 2008-02-21 | 2009-02-20 | アミド誘導体及びそれを含有する医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1145837A1 true HK1145837A1 (en) | 2011-05-06 |
Family
ID=40985606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK11100055.9A HK1145837A1 (en) | 2008-02-21 | 2011-01-05 | Amide derivative and pharmaceutical composition containing the same |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7906510B2 (ja) |
| EP (1) | EP2256114B1 (ja) |
| JP (1) | JP5101639B2 (ja) |
| KR (1) | KR101586507B1 (ja) |
| CN (1) | CN102015697B (ja) |
| AU (1) | AU2009216149B2 (ja) |
| BR (1) | BRPI0907833A2 (ja) |
| CA (1) | CA2713412C (ja) |
| ES (1) | ES2478042T3 (ja) |
| HK (1) | HK1145837A1 (ja) |
| IL (1) | IL207423A (ja) |
| MX (1) | MX2010009244A (ja) |
| RU (1) | RU2481343C2 (ja) |
| TW (1) | TWI423967B (ja) |
| WO (1) | WO2009104729A1 (ja) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107513044A (zh) * | 2017-09-20 | 2017-12-26 | 安徽修制药有限公司 | 一种枸橼酸莫沙必利的绿色环保合成方法 |
| WO2019131891A1 (ja) * | 2017-12-28 | 2019-07-04 | 大日本住友製薬株式会社 | 苦味がマスキングされた薬物含有粒子及び該薬物含有粒子を含む製剤 |
| US20210369624A1 (en) * | 2018-06-01 | 2021-12-02 | Sumitomo Dainippon Pharma Co., Ltd. | Solid oral dosage form having excellent dissolution properties |
| CN110938068B (zh) * | 2019-11-06 | 2022-12-23 | 广东东阳光药业有限公司 | N-(吗啉-2-基甲基)酰胺衍生物及其用途 |
| CN115975210B (zh) * | 2023-01-14 | 2023-07-14 | 厦门立方幻境科技有限公司 | 一种医用硅胶及其制备方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ284687B6 (cs) * | 1986-04-30 | 1999-02-17 | Dainippon Pharmaceutical Co., Ltd. | Substituovaný benzamidový derivát, způsob jeho výroby a farmaceutický prostředek na jeho bázi |
| JPS63264467A (ja) * | 1986-04-30 | 1988-11-01 | Dainippon Pharmaceut Co Ltd | ベンズアミド誘導体 |
| TW213460B (ja) | 1991-02-15 | 1993-09-21 | Hokuriku Pharmaceutical | |
| US5395832A (en) * | 1991-02-15 | 1995-03-07 | Hokuriku Seiyaku Co., Ltd. | Benzamide derivatives |
| ATE208766T1 (de) * | 1995-05-23 | 2001-11-15 | Janssen Pharmaceutica Nv | (2-morpholinylmethyl)benzamid-derivate |
| JPH111472A (ja) | 1996-04-30 | 1999-01-06 | Dainippon Pharmaceut Co Ltd | ベンズアミド誘導体及びそれを含有する医薬組成物 |
| EP1076055B1 (en) * | 1998-04-28 | 2004-11-24 | Dainippon Pharmaceutical Co., Ltd. | 1- (1-substituted-4-piperidinyl)methyl]-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds |
| JP2000080081A (ja) | 1998-06-24 | 2000-03-21 | Dainippon Pharmaceut Co Ltd | １―〔（１―置換―４―ピペリジニル）メチル〕―４―ピペリジン誘導体及びそれを含有する医薬組成物 |
| JP2001122784A (ja) | 1999-10-27 | 2001-05-08 | Dainippon Pharmaceut Co Ltd | １−［（１−置換−４−ピペリジニル）メチル］−４−ピペリジン誘導体からなる医薬 |
| EP1289965B1 (en) * | 2000-05-25 | 2005-10-26 | F. Hoffmann-La Roche Ag | Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| US6696468B2 (en) * | 2002-05-16 | 2004-02-24 | Dainippon Pharmaceutical Co., Ltd. | (s)-4-amino-5-chloro-2-methoxy-n-[1-[1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor |
| JP2004277320A (ja) | 2003-03-14 | 2004-10-07 | Dainippon Pharmaceut Co Ltd | １，４−ジ置換ピペリジン誘導体およびそれを含有する医薬組成物 |
| JP2004277319A (ja) | 2003-03-14 | 2004-10-07 | Dainippon Pharmaceut Co Ltd | １−（４−ピペリジニルメチル）ピペリジニルアミド誘導体およびそれを含有する医薬組成物 |
| JP2004277318A (ja) | 2003-03-14 | 2004-10-07 | Dainippon Pharmaceut Co Ltd | １−（１−置換カルボニル−４−ピペリジニルメチル）ピペリジン誘導体およびそれを含有する医薬組成物 |
| JP2005082508A (ja) | 2003-09-05 | 2005-03-31 | Dainippon Pharmaceut Co Ltd | ２−アルコキシ−６−アミノ−５−ハロゲノ−ｎ−（１−置換−４−ピペリジニル）ピリジン−３−カルボキサミド誘導体およびそれを含有する医薬組成物 |
| JP2005104896A (ja) | 2003-09-30 | 2005-04-21 | Dainippon Pharmaceut Co Ltd | ２−アルコキシ−６−アミノ−５−ハロゲノピリジン−３−カルボキサミド誘導体およびそれを含有する医薬組成物 |
| JP2005170933A (ja) | 2003-11-14 | 2005-06-30 | Dainippon Pharmaceut Co Ltd | （ｓ）−４−アミノ−５−クロロ−２−メトキシ−ｎ−［１−［１−（２−テトラヒドロフリルカルボニル）−４−ピペリジニルメチル］−４−ピペリジニル］ベンズアミドからなる医薬 |
-
2009
- 2009-02-19 TW TW098105307A patent/TWI423967B/zh active
- 2009-02-20 RU RU2010138788/04A patent/RU2481343C2/ru not_active IP Right Cessation
- 2009-02-20 KR KR1020107017907A patent/KR101586507B1/ko active IP Right Grant
- 2009-02-20 WO PCT/JP2009/053011 patent/WO2009104729A1/ja active Application Filing
- 2009-02-20 JP JP2009554392A patent/JP5101639B2/ja active Active
- 2009-02-20 EP EP09711609.9A patent/EP2256114B1/en active Active
- 2009-02-20 US US12/734,224 patent/US7906510B2/en active Active
- 2009-02-20 BR BRPI0907833A patent/BRPI0907833A2/pt not_active IP Right Cessation
- 2009-02-20 MX MX2010009244A patent/MX2010009244A/es active IP Right Grant
- 2009-02-20 CN CN200980114696.8A patent/CN102015697B/zh not_active Expired - Fee Related
- 2009-02-20 ES ES09711609.9T patent/ES2478042T3/es active Active
- 2009-02-20 AU AU2009216149A patent/AU2009216149B2/en not_active Ceased
- 2009-02-20 CA CA2713412A patent/CA2713412C/en active Active
-
2010
- 2010-08-05 IL IL207423A patent/IL207423A/en not_active IP Right Cessation
-
2011
- 2011-01-05 HK HK11100055.9A patent/HK1145837A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2713412A1 (en) | 2009-08-27 |
| JP5101639B2 (ja) | 2012-12-19 |
| IL207423A0 (en) | 2010-12-30 |
| TWI423967B (zh) | 2014-01-21 |
| AU2009216149A1 (en) | 2009-08-27 |
| RU2481343C2 (ru) | 2013-05-10 |
| KR101586507B1 (ko) | 2016-01-19 |
| JPWO2009104729A1 (ja) | 2011-06-23 |
| EP2256114A4 (en) | 2012-05-09 |
| CA2713412C (en) | 2016-03-22 |
| EP2256114B1 (en) | 2014-06-25 |
| CN102015697A (zh) | 2011-04-13 |
| US7906510B2 (en) | 2011-03-15 |
| MX2010009244A (es) | 2010-09-24 |
| WO2009104729A1 (ja) | 2009-08-27 |
| ES2478042T3 (es) | 2014-07-18 |
| KR20100126684A (ko) | 2010-12-02 |
| RU2010138788A (ru) | 2012-03-27 |
| TW200951129A (en) | 2009-12-16 |
| US20100249399A1 (en) | 2010-09-30 |
| BRPI0907833A2 (pt) | 2016-08-02 |
| EP2256114A1 (en) | 2010-12-01 |
| CN102015697B (zh) | 2015-06-17 |
| IL207423A (en) | 2016-06-30 |
| AU2009216149B2 (en) | 2013-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS1800043I1 (hu) | 514 számú gyógyszerkészítmény | |
| IL242883B (en) | Aryl-amino and heteroaryl-amino converted deoxazolines and pharmaceutical preparations containing them | |
| EP2143713A4 (en) | NEW PYRROLINONE DERIVATIVE AND MEDICAL COMPOSITION CONTAINING THIS | |
| EP2336109A4 (en) | NOVEL PYRROLINONE DERIVATIVE AND DRUG COMPOSITION CONTAINING THE SAME | |
| IL206594A (en) | The history of azinone-tetrahydropyridoindole and its containing pharmaceutical preparations | |
| ZA201002547B (en) | Heterocyclic compound and pharmaceutical composition thereof | |
| HK1145461A1 (en) | Benzodiazepine compound and pharmaceutical composition | |
| PL2364975T3 (pl) | Nowa pochodna amidu i jej zastosowanie jako lek | |
| PL2320739T3 (pl) | Kompozycje farmaceutyczne i sposoby ich stabilizowania | |
| HK1156844A1 (en) | Pharmaceutical composition 271 271 | |
| HK1145837A1 (en) | Amide derivative and pharmaceutical composition containing the same | |
| EP2279999A4 (en) | RETINOID DERIVATIVE AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
| EP2402333A4 (en) | 1,4-BENZOTHIAZEPINE 1-OXIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION USING THE SAME | |
| EP2233467A4 (en) | ALPHA-AMINO N-SUBSTITUTED AMIDES, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND USES THEREOF | |
| EP2263671A4 (en) | PHARMACEUTICAL COMPOSITION CONTAINING AN AMIDE DERIVATIVE | |
| AP2734A (en) | Pharmaceutical carrier composition and pharmaceutical composition | |
| EP2275437A4 (en) | POLYPEPTIDE AND PHARMACEUTICAL COMPOSITION CONTAINING THE POLYPEPTIDE | |
| GB0701295D0 (en) | Z-stilbenes derivatives and the pharmaceutical composition thereof | |
| TWI365071B (en) | Isoxazole derivatives and pharmaceutical compositions comprising the same | |
| SI2271321T1 (sl) | Farmacevtski sestavek 271 | |
| AP2007004032A0 (en) | Pharmaceutical carrier composition and pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230220 |